gmi research logo
GMI Research
See the Future Insights
GMI Research Facebook Page GMI Research Twitter Page GMI Research Linkedin Page
U.S Office +1 860 881 2270 : Europe Office +353 1 442 8820  

Global Migraine Drugs Market by Drug Type (Abortive Drugs and Preventive Drugs), by Route of Administration (Oral, Injectables and Others), End User (Hospital Pharmacies, Retail Pharmacies and Others), and by Geography - Opportunities & Forecast, 2018-2025

Get Free 20% Customization in this Report


Report Code : HM19A-00-1218 Published Date: October-2018 Report Format: PPT

 

Select License Type:

Need Assitance ?


A GMI Research Sales Representative
is available to help you

U.S Office +1 860 881 2270

Europe Office +353 1 442 8820


Migraine is a neurological disorder that causes severe pain in head and results in nausea, vomiting, and extreme sensitivity to light and sound. The common types of migraine are with aura and without aura that means classical migraines and common migraines.


According to migraine trust website, in 2016, migraine headaches affected about 12.0% to 14.7% of population across the globe. Migraine has been categorized by frequency and nature of attack into episodic migraine and chronic migraine as per international as well regional guidelines. Migraine is an extraordinarily prevalent neurological disease, affecting 39 million men, women and children in the US and 1 billion worldwide. As per World Health Organization (WHO) in 2016, about 50% of migraine disorders were reported, out of which, women patients were more.


Rise in prevalence of migraine in the age group of 30 to 40 drives the migraine drugs market. Moreover, increase in female population and surge in awareness among patients related to prevention and treatment of migraine are the key factors that augment the growth of the market. However, side effects like fatigue, nausea, lowering of blood pressure, etc., associated with migraine drugs is a factor that hinders the market growth. Migraine disorders are among the most common disorders of the nervous system, mostly observed in adult population. Furthermore, North America holds the largest share in the migraine drugs market as it has large number of ageing population.


Various notable players operating in the global migraine drugs market include Abbott Laboratories, Aegis Therapeutics, LLC, Aerial Biopharma LLC, Alder Biopharmaceuticals Inc., Amgen Inc, Astellas Pharma, AstraZeneca, Johnsons and Johnsons, Eisai Co Ltd, Eli Lily & Co and others.


The global migraine drugs market has been segmented on the basis of drug type, route of administration, end user and key geographies. Based on the drug type, the market comprises of abortive drugs and preventive drugs. Based on route of administration, the market is classified into Oral, Injectables and Others. Based on end user market is segmented into Hospital pharmacies, retail pharmacies and others.


This research report “global migraine drugs market” provides in-depth analysis of the migraine drugs market across the globe based on drug type, route of administration, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers propelling the growth as well as challenges faced by market participants. The research report provides market size and forecast for migraine drugs market. The report also analyses the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

 

Key questions answered in this research report:
1-    At what pace is migraine drugs market growing worldwide? What will be growth trend in future?
2-    What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints in the future?
3-    What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the migraine drugs market?
4-    What are the various application areas and how they are poised to grow?


The global migraine drugs market has been segmented based on drug type, route of administration, end user and geography:
 
Global Migraine Drugs Market, by Drug Type
•    Abortive Drugs
•    Preventive Drugs


Global Migraine Drugs Market, by Route of Administration

•    Oral
•    Injectables
•    Others (Nasal Spray, Transdermal Path, etc.)


Global Migraine Drugs Market, by End User
•    Hospitals Pharmacies
•    Retail Pharmacies
•    Others


Global Migraine Drugs Market, by Geography
•    North America
As a part of customization
o    By Drug Type
o    By Route of Administration
o    By End User
o    United States
o    Canada
o    Mexico


•    Europe
As a part of customization
o    By Drug Type
o    By Route of Administration
o    By End User
o    United Kingdom
o    Germany
o    Spain
o    Rest of Europe

•    Asia-Pacific
As a part of customization
o    By Drug Type
o    By Route of Administration
o    By End User
o    China
o    Japan
o    India
o    Rest of Asia-Pacific


•    Rest of the World
As a part of customization
o    By Drug Type
o    By Route of Administration
o    By End User
o    Brazil
o    GCC countries
o    South Africa
o    Rest of ROW

Global Migraine Drugs Market Competitive Landscape

•    Major Players and their Key Strategies
•    New Drug Launches
•    Mergers and Acquisitions
•    Collaborations, Partnerships, Agreements and Joint Ventures


Leading Market Players
•    Abbott Laboratories
•    Aegis Therapeutics, LLC
•    Aerial Biopharma LLC
•    Alder Biopharmaceuticals Inc.,
•    Amgen Inc Lucibel SA
•    Astellas Pharma.
•    AstraZeneca Velmenni OÜ
•    Johnsons and Johnsons
•    Eisai Co Ltd
•    Eli Lily & Co
Other prominent players in the market which can be profiled as a part of customization:
•     Teva Pharmaceutical Industries Ltd.
•     GlaxoSmithKline plc
•     Novartis AG
•    Merck & Co., Inc.,

Request TOC

First Name* :
Last Name* :
Report Title* :
Company Name* :
E-mail* :
Phone No.* :
Address :
City* :
State* :
Country* :
Zip Code* :
Verification Code* : captcha